DC Field | Value | Language |
---|---|---|
dc.contributor.author | K Lee | - |
dc.contributor.author | S H Cho | - |
dc.contributor.author | J H Lee | - |
dc.contributor.author | J Goo | - |
dc.contributor.author | S Y Lee | - |
dc.contributor.author | S K Boovanahalli | - |
dc.contributor.author | S K Yeo | - |
dc.contributor.author | S J Lee | - |
dc.contributor.author | Young Kook Kim | - |
dc.contributor.author | D H Kim | - |
dc.contributor.author | Y Choi | - |
dc.contributor.author | G Y Song | - |
dc.date.accessioned | 2017-04-19T09:36:51Z | - |
dc.date.available | 2017-04-19T09:36:51Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | 10.1016/j.ejmech.2013.01.020 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/11192 | - |
dc.description.abstract | We report a new series of naphthoquinone derivatives as potent ACAT inhibitors, which were obtained through structural variations of previously disclosed lead 1. Several analogs represented by 3i-l, 4k-m, 6a-n, 7a, and 7i demonstrated potent human macrophage ACAT inhibitory activity by a cell-based reporter assay with human HepG2 cell lines. In particular, compounds 4l and 6j emerged as highly potent inhibitors, exhibiting significantly high inhibitory potencies with IC50 values of 0.44 μM and 0.6 μM, respectively. Moreover, compound 4l significantly reduced the accumulation of cellular cholesterol in HepG2 cell lines. | - |
dc.publisher | Elsevier | - |
dc.title | Synthesis of a novel series of 2-alkylthio substituted naphthoquinones as potent acyl-CoA: Cholesterol acyltransferase (ACAT) inhibitors | - |
dc.title.alternative | Synthesis of a novel series of 2-alkylthio substituted naphthoquinones as potent acyl-CoA: Cholesterol acyltransferase (ACAT) inhibitors | - |
dc.type | Article | - |
dc.citation.title | European Journal of Medicinal Chemistry | - |
dc.citation.number | 0 | - |
dc.citation.endPage | 525 | - |
dc.citation.startPage | 515 | - |
dc.citation.volume | 62 | - |
dc.contributor.affiliatedAuthor | Young Kook Kim | - |
dc.contributor.alternativeName | 이경 | - |
dc.contributor.alternativeName | 조수현 | - |
dc.contributor.alternativeName | 이지현 | - |
dc.contributor.alternativeName | 구자일 | - |
dc.contributor.alternativeName | 이성윤 | - |
dc.contributor.alternativeName | Boovanahalli | - |
dc.contributor.alternativeName | 여석균 | - |
dc.contributor.alternativeName | 이성준 | - |
dc.contributor.alternativeName | 김영국 | - |
dc.contributor.alternativeName | 김동희 | - |
dc.contributor.alternativeName | 최용석 | - |
dc.contributor.alternativeName | 송규용 | - |
dc.identifier.bibliographicCitation | European Journal of Medicinal Chemistry, vol. 62, pp. 515-525 | - |
dc.identifier.doi | 10.1016/j.ejmech.2013.01.020 | - |
dc.subject.keyword | ACAT inhibitors | - |
dc.subject.keyword | Cellular cholesterol | - |
dc.subject.keyword | LDL | - |
dc.subject.keyword | Naphthoquinones | - |
dc.subject.keyword | Triglycerides | - |
dc.subject.keyword | VLDL | - |
dc.subject.local | ACAT inhibitor | - |
dc.subject.local | ACAT inhibitors | - |
dc.subject.local | Cellular cholesterol | - |
dc.subject.local | LDL | - |
dc.subject.local | Naphthoquinones | - |
dc.subject.local | triglyceride | - |
dc.subject.local | Triglycerides | - |
dc.subject.local | Triglyceride | - |
dc.subject.local | triglyceride (TG) | - |
dc.subject.local | VLDL | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.